Annual Interest Expense
$26.94 M
-$1.11 M-3.96%
31 December 2023
Summary:
ANI Pharmaceuticals annual interest expense is currently $26.94 million, with the most recent change of -$1.11 million (-3.96%) on 31 December 2023. During the last 3 years, it has risen by +$17.49 million (+185.02%). ANIP annual interest expense is now -3.96% below its all-time high of $28.05 million, reached on 31 December 2022.ANIP Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$2.33 M
-$2.33 M-49.94%
30 September 2024
Summary:
ANI Pharmaceuticals quarterly interest expense is currently $2.33 million, with the most recent change of -$2.33 million (-49.94%) on 30 September 2024. Over the past year, it has dropped by -$4.07 million (-63.57%). ANIP quarterly interest expense is now -69.71% below its all-time high of $7.70 million, reached on 31 March 2023.ANIP Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$17.33 M
-$4.07 M-19.00%
30 September 2024
Summary:
ANI Pharmaceuticals TTM interest expense is currently $17.33 million, with the most recent change of -$4.07 million (-19.00%) on 30 September 2024. Over the past year, it has dropped by -$11.37 million (-39.61%). ANIP TTM interest expense is now -41.38% below its all-time high of $29.57 million, reached on 30 June 2023.ANIP TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIP Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.0% | -63.6% | -39.6% |
| 3 y3 years | +185.0% | -6.7% | +72.7% |
| 5 y5 years | +82.5% | -30.1% | +26.3% |
ANIP Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -4.0% | +185.0% | -69.7% | at low | -41.4% | +72.7% |
| 5 y | 5 years | -4.0% | +185.0% | -69.7% | +14.7% | -41.4% | +83.4% |
| alltime | all time | -4.0% | -69.7% | -41.4% |
ANI Pharmaceuticals Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.33 M(-49.9%) | $17.33 M(-19.0%) |
| June 2024 | - | $4.66 M(+1.2%) | $21.40 M(-10.2%) |
| Mar 2024 | - | $4.60 M(-19.9%) | $23.84 M(-11.5%) |
| Dec 2023 | $26.94 M(-4.0%) | $5.75 M(-10.2%) | $26.94 M(-6.1%) |
| Sept 2023 | - | $6.40 M(-9.9%) | $28.70 M(-2.9%) |
| June 2023 | - | $7.10 M(-7.7%) | $29.57 M(+1.5%) |
| Mar 2023 | - | $7.70 M(+2.5%) | $29.14 M(+3.9%) |
| Dec 2022 | $28.05 M(+135.3%) | $7.51 M(+3.3%) | $28.05 M(+12.3%) |
| Sept 2022 | - | $7.26 M(+8.9%) | $24.99 M(+23.6%) |
| June 2022 | - | $6.67 M(+0.8%) | $20.22 M(+25.7%) |
| Mar 2022 | - | $6.61 M(+48.9%) | $16.08 M(+34.9%) |
| Dec 2021 | $11.92 M(+26.1%) | $4.44 M(+77.8%) | $11.92 M(+18.8%) |
| Sept 2021 | - | $2.50 M(-1.3%) | $10.04 M(-0.1%) |
| June 2021 | - | $2.53 M(+3.1%) | $10.05 M(+1.8%) |
| Mar 2021 | - | $2.45 M(-3.9%) | $9.87 M(+4.5%) |
| Dec 2020 | $9.45 M(-27.1%) | $2.55 M(+1.8%) | $9.45 M(-3.2%) |
| Sept 2020 | - | $2.51 M(+6.5%) | $9.77 M(-7.8%) |
| June 2020 | - | $2.36 M(+15.9%) | $10.59 M(-9.0%) |
| Mar 2020 | - | $2.03 M(-29.2%) | $11.64 M(-10.2%) |
| Dec 2019 | $12.97 M(-12.1%) | $2.87 M(-14.0%) | $12.97 M(-5.5%) |
| Sept 2019 | - | $3.34 M(-2.1%) | $13.72 M(-3.1%) |
| June 2019 | - | $3.41 M(+1.6%) | $14.15 M(-2.2%) |
| Mar 2019 | - | $3.35 M(-7.5%) | $14.48 M(-1.9%) |
| Dec 2018 | $14.76 M(+22.6%) | $3.63 M(-3.8%) | $14.76 M(+4.2%) |
| Sept 2018 | - | $3.77 M(+1.0%) | $14.16 M(+5.3%) |
| June 2018 | - | $3.73 M(+2.6%) | $13.44 M(+5.5%) |
| Mar 2018 | - | $3.63 M(+20.1%) | $12.74 M(+5.8%) |
| Dec 2017 | $12.04 M | $3.03 M(-0.9%) | $12.04 M(+1.4%) |
| Sept 2017 | - | $3.05 M(+0.9%) | $11.87 M(+1.7%) |
| June 2017 | - | $3.02 M(+3.2%) | $11.67 M(+1.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $2.93 M(+2.6%) | $11.48 M(+1.3%) |
| Dec 2016 | $11.33 M(+2.9%) | $2.86 M(+0.1%) | $11.33 M(+0.8%) |
| Sept 2016 | - | $2.86 M(+0.9%) | $11.24 M(+0.8%) |
| June 2016 | - | $2.83 M(+1.7%) | $11.15 M(+0.7%) |
| Mar 2016 | - | $2.78 M(+0.5%) | $11.06 M(+0.5%) |
| Dec 2015 | $11.01 M(+1298.7%) | $2.77 M(+0.1%) | $11.01 M(+33.6%) |
| Sept 2015 | - | $2.77 M(+0.6%) | $8.24 M(+50.5%) |
| June 2015 | - | $2.75 M(+0.9%) | $5.47 M(+100.9%) |
| Mar 2015 | - | $2.73 M(>+9900.0%) | $2.73 M(>+9900.0%) |
| Dec 2014 | $787.00 K(+68.5%) | - | - |
| Mar 2014 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2013 | $467.00 K(+34.2%) | - | - |
| Mar 2013 | - | $64.70 K(0.0%) | $288.50 K(-17.1%) |
| Dec 2012 | $348.00 K(-48.9%) | $64.70 K(-3.6%) | $348.00 K(-22.5%) |
| Sept 2012 | - | $67.10 K(-27.1%) | $448.90 K(-18.9%) |
| June 2012 | - | $92.00 K(-25.9%) | $553.80 K(-12.6%) |
| Mar 2012 | - | $124.20 K(-25.0%) | $633.80 K(-7.0%) |
| Dec 2011 | $681.60 K(-0.9%) | $165.60 K(-3.7%) | $681.60 K(-0.9%) |
| Sept 2011 | - | $172.00 K(0.0%) | $688.00 K(0.0%) |
| June 2011 | - | $172.00 K(0.0%) | $688.00 K(-0.0%) |
| Mar 2011 | - | $172.00 K(0.0%) | $688.10 K(0.0%) |
| Dec 2010 | $688.10 K(+368.1%) | $172.00 K(0.0%) | $688.10 K(+3.8%) |
| Sept 2010 | - | $172.00 K(-0.1%) | $663.10 K(+35.0%) |
| June 2010 | - | $172.10 K(+0.1%) | $491.10 K(+53.9%) |
| Mar 2010 | - | $172.00 K(+17.0%) | $319.00 K(+117.0%) |
| Dec 2009 | $147.00 K(>+9900.0%) | $147.00 K(>+9900.0%) | $147.00 K(>+9900.0%) |
| Sept 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2009 | - | $0.00 | $0.00 |
| Dec 2008 | $0.00 | - | - |
FAQ
- What is ANI Pharmaceuticals annual interest expense?
- What is the all time high annual interest expense for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual interest expense year-on-year change?
- What is ANI Pharmaceuticals quarterly interest expense?
- What is the all time high quarterly interest expense for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly interest expense year-on-year change?
- What is ANI Pharmaceuticals TTM interest expense?
- What is the all time high TTM interest expense for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals TTM interest expense year-on-year change?
What is ANI Pharmaceuticals annual interest expense?
The current annual interest expense of ANIP is $26.94 M
What is the all time high annual interest expense for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual interest expense is $28.05 M
What is ANI Pharmaceuticals annual interest expense year-on-year change?
Over the past year, ANIP annual interest expense has changed by -$1.11 M (-3.96%)
What is ANI Pharmaceuticals quarterly interest expense?
The current quarterly interest expense of ANIP is $2.33 M
What is the all time high quarterly interest expense for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly interest expense is $7.70 M
What is ANI Pharmaceuticals quarterly interest expense year-on-year change?
Over the past year, ANIP quarterly interest expense has changed by -$4.07 M (-63.57%)
What is ANI Pharmaceuticals TTM interest expense?
The current TTM interest expense of ANIP is $17.33 M
What is the all time high TTM interest expense for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high TTM interest expense is $29.57 M
What is ANI Pharmaceuticals TTM interest expense year-on-year change?
Over the past year, ANIP TTM interest expense has changed by -$11.37 M (-39.61%)